The global peripheral intravenous catheters market to reach USD 2.3 billion by 2025, growing at a CAGR of over 4% during the forecast period. The global peripheral intravenous catheters (PIVCs) market is growing at a steady rate due to the rising incidence of trauma cases (accident and burn cases), the growing prevalence of chronic diseases, and increasing hospital-acquired infections. The market growth is also driven by the rising volume of hospitalization and the demand for chemotherapy procedures requiring intravenous catheters to deliver medicine, nutrition, and fluids to the patient. The use of safety peripheral I.V. catheters is one of the major factors driving growth. Although safety needles are more expensive than conventional needles, their price is likely to decline during the forecast period due to government initiatives that promote the use of safety needles. Vendors are partnering with distributors for the bulk supply of PIVCs to end-users.
Another major driver influencing the growth of the peripheral I.V. catheters market is the demand for midline I.V. catheters. They are unique vascular access devices, which are inserted in the peripheral veins of the upper extremity. They terminate in the peripheral veins without extending into the central veins. Hence, the incidence of central line-associated bloodstream infections (CLABSIs) is minimal with the usage of midline I.V. catheters. Many healthcare settings prefer using them to avoid CLABSIs. Midline PIVCs also offer significantly better hemodilution than conventional ones placed in smaller, more distal veins because of the placement of the tip in one of the larger veins of the upper arm.
- The short peripheral I.V. catheters market is likely to grow with the highest incremental growth of over $448 million during the forecast period.
- APAC is expected to grow at the fastest CAGR of over 6%. As the adoption of advanced safety PIVCs is becoming popular in the region, the demand for technically advanced devices is likely to be increased at a significant rate in the coming years
- The conventional peripheral IV catheters market is likely to dominate the market with a CAGR of over 6% by 2025
- The application of short PIVCs is expected to grow over midline PIVCs as these catheters help to avoid blood-borne infections, HIV, and other associated risks.
PERIPHERAL INTRAVENOUS CATHETERS MARKET SEGMENTATION
This research report includes a detailed segmentation by
INSIGHTS BY PRODUCTS
With the steady demand for safe short PIVCs, vendors are focusing on manufacturing I.V. catheters, with non-irritant, flexible, kink-resistant, and user-friendly materials such as polyurethane. The peripheral intravenous catheters market is growing at a fast rate due to the rising awareness of needlestick injuries and bloodborne infections among patients. As there is a rise in the number of hospitalizations, the demand for short peripheral I.V. catheters is growing as they are used for a short duration of around 72–96 hours, thereby decreasing contamination chances. Moreover, advances in minimizing the infection rate will generate lucrative opportunities for key players, thus boosting the growth in upcoming years.
The increasing hospital admissions for more than one week are driving the demand for the midline PIVCs market. Patients do not need to strike multiple times for frequent IV restart while using midline PIVCs. Besides, there are several advantages, which include avoiding repeated venipunctures and decreasing the incidence of catheter-related infections.
INSIGHTS BY END-USERS
The transformation in the healthcare sector has led to the use of a diverse range of IV catheters in hospitals. The purchase is higher in hospitals and other medical facilities. The bulk purchase helps in the procurement at discounted rates. Hospitals have tie-ups with distributors and vendors for the supply of medical products. Private clinics and practitioners usually procure PIVCs from distributors, as they face difficulties in establishing direct contacts with manufacturers because of their low volume purchases.
The ambulatory care settings (ACS) segment is expected to dominate the peripheral intravenous catheters market. This growth can be attributed to the use in surgery care settings as PIVCs help to supply drugs, nutrients, and blood during surgeries. A lot of the patient population prefers ACS due to same-day surgery and high-class treatment availability. The growing incidence of surgical site infections (SSIs) has forced ACS to implement safe injection practices to minimize the spread of blood-borne infections. The increasing patient preference for ASCs to perform surgeries has led to high demand for PIVCs.
INSIGHTS BY TECHNOLOGY
In 2019, the conventional segment was growing at a significant rate, and the trend is likely to continue during the forecast period. The growth of the segment is majorly due to the high preference for low-cost affordability in emerging economies and the lack of awareness of safe needles practices in the population. Moreover, the easy availability of conventional catheters is driving the segment in developing economies. Also, the high prevalence of chronic diseases is contributing to the usage of conventional PIVCs. However, the high inclination toward safe catheters is likely to decrease the market segment.
The Safety PIVCs market is growing at a rapid growth rate. The increase in the patient population and the growth in hospital admission are driving the segment worldwide. Vendors are increasingly focusing on offering diversified safety peripheral intravenous catheters to provide safe patient care and avoid infections.
INSIGHTS BY GEOGRAPHY
North America is a major market due to the growing incidence of chronic diseases and an efficient distribution network of medical devices. The region has advanced hospital infrastructure and facilities with the focus on avoiding infections and cross-contamination and providing high patient safety by opting for safe integrated I.V. catheters and midline ones. As there is high awareness regarding PIVCs and associated complications, the adoption is increasing rapidly in the region. The US is the major revenue contributor to the North America PIVCs market.
The European peripheral intravenous catheters market is experiencing at a slower rate than APAC, Latin America, and Middle East & Africa regions; however, the region is the second-largest market. Medical devices, including peripheral intravenous catheters, are subjected to general safety requirements prescribed by regulatory bodies. The rise in chronic diseases and rising demand for the use of retractable & safety needles are propelling the growth in Europe.
The APAC market is growing at a significant rate, which is expected to continue during the forecast period. The healthcare system in the region is undergoing rapid transformations with favorable support from government organizations. China, Japan, India, South Korea, and Australia are the major revenue contributors in the APAC region.
The Latin America region is experiencing healthy growth in the healthcare sector, including medical devices, due to the growth in overall GDP in several countries. The overall GDP of Latin America grew to 3.7% in 2016 from 2.9% in 2014. The availability of advanced healthcare infrastructure is expected to increase the usage of advanced medical devices such as PIVCs to avoid infections, thereby contributing to the growth in the region.
The prevalence of communicable and non-communicable diseases such as cancer, diabetes, and obesity is increasing in the Middle East and Africa. According to the WHO, around 422 million people have diabetes across the globe, out of which 43 million are estimated to be from the Middle Eastern region. This growing number of patients increases hospital admissions, which eventually drives the peripheral I.V. catheters demand in the region. HIV is widely prevalent in Africa. Of 34 million HIV-positive people worldwide, about 70% resided in Africa in 2016. Hence, the region is witnessing an increasing demand for PIVCs to administer several drugs.
INSIGHTS BY VENDORS
The global peripheral intravenous catheters market is highly competitive and characterized by the presence of a few key players and a significant number of other prominent players offering a wide range of advanced and innovative cardiac prosthetic devices. The market is witnessing rapid technological advancements and is significantly affected by new product launches. Abbott, BIOTRONIK, Boston Scientific, Edwards Lifesciences, and Medtronic are the major players with dominant shares in the peripheral intravenous catheters market. The dominant presence of major players is attributable to their strong presence and endorsement for their products due to the availability of abundant clinical data/evidence regarding safety and efficacy.
The peripheral intravenous catheters market research report includes in-depth coverage of the industry with revenues & forecasts for the following segments:
Market Segmentation by Products
- Short PIVC
- Midline IV Catheter
- Conventional PIVC
- Safety PIVC
- Specialty Cardiac Centers
- North America
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa